Kymera Therapeutics (NasdaqGM:KYMR) FY Conference December 02, 2025 02:30 PM ET Company ParticipantsNello Mainolfi - Founder, President, and CEOConference Call ParticipantsTed Tenthoff - Senior Biotechnology AnalystTed TenthoffGood evening, everyone. My name is Ted Tenthoff. I'm a senior biotech analyst at Piper Sandler, and before I begin, I'm required to point out certain disclosures regarding the relationship between Piper and our next presenting company, Kymera, which are posted both at the back of the ...